Global Human Microbiome Sequencing Technology Market Research Report 2022

Report Format: PDF   |   Report ID: 5514478   |   Published Date: August 2022   |   Pages:  115  

Choose License
Market Analysis and Insights: Global Human Microbiome Sequencing Technology Market
The global Human Microbiome Sequencing Technology market size is projected to reach US$  million by 2028, from US$  million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Traditional Sequencing Technologies accounting for % of the Human Microbiome Sequencing Technology global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While Research and Academic Institutions segment is altered to an % CAGR throughout this forecast period.
China Human Microbiome Sequencing Technology market size is valued at US$  million in 2021, while the North America and Europe Human Microbiome Sequencing Technology are US$  million and US$  million, severally. The proportion of the North America is  % in 2021, while China and Europe are  % and respectively, and it is predicted that China proportion will reach  % in 2028, trailing a CAGR of  % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR  %,  %, and   % respectively for the next 6-year period. As for the Europe Human Microbiome Sequencing Technology landscape, Germany is projected to reach US$  million by 2028 trailing a CAGR of  % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Microbiome Sequencing Technology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Microbiome Sequencing Technology market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Microbiome Sequencing Technology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Microbiome Sequencing Technology market.
Global Human Microbiome Sequencing Technology Scope and Market Size
Human Microbiome Sequencing Technology market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Human Microbiome Sequencing Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
    Traditional Sequencing Technologies
    Next-Generation Sequencing
    Third Generation Sequencing
Segment by Application
    Research and Academic Institutions
    Pharmaceutical and Biotechnology Companies
    Hospital and Clinic
    Others
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
By Company
    Baseclear B.V.
    Beijing Genomics Institute (BGI) Genomics Co., Ltd
    Charles River Laboratories International Inc.
    Clinical Microbiomics A/S
    Eurofins Scientific SE
    GENEWIZ, Inc.
    Illumina, Inc.
    Novogene Corporation
    OraSure Technologies, Inc.
    Oxford Nanopore Technologies, Inc.
    Pacific Biosciences of California, Inc.
    QIAGEN N.V.
    Second Genome, Inc.
    Thermo Fisher Scientific Inc.
    Viome, Inc.
    CosmosID
    Leucine Rich Bio Pvt. Ltd.
    Microba
    Microbiome Insights Inc.
    Molzym GmbH & Co. KG
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Human Microbiome Sequencing Technology Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Traditional Sequencing Technologies
        1.2.3 Next-Generation Sequencing
        1.2.4 Third Generation Sequencing
    1.3 Market by Application
        1.3.1 Global Human Microbiome Sequencing Technology Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Research and Academic Institutions
        1.3.3 Pharmaceutical and Biotechnology Companies
        1.3.4 Hospital and Clinic
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Human Microbiome Sequencing Technology Market Perspective (2017-2028)
    2.2 Human Microbiome Sequencing Technology Growth Trends by Region
        2.2.1 Human Microbiome Sequencing Technology Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Human Microbiome Sequencing Technology Historic Market Size by Region (2017-2022)
        2.2.3 Human Microbiome Sequencing Technology Forecasted Market Size by Region (2023-2028)
    2.3 Human Microbiome Sequencing Technology Market Dynamics
        2.3.1 Human Microbiome Sequencing Technology Industry Trends
        2.3.2 Human Microbiome Sequencing Technology Market Drivers
        2.3.3 Human Microbiome Sequencing Technology Market Challenges
        2.3.4 Human Microbiome Sequencing Technology Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Human Microbiome Sequencing Technology Players by Revenue
        3.1.1 Global Top Human Microbiome Sequencing Technology Players by Revenue (2017-2022)
        3.1.2 Global Human Microbiome Sequencing Technology Revenue Market Share by Players (2017-2022)
    3.2 Global Human Microbiome Sequencing Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Human Microbiome Sequencing Technology Revenue
    3.4 Global Human Microbiome Sequencing Technology Market Concentration Ratio
        3.4.1 Global Human Microbiome Sequencing Technology Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Sequencing Technology Revenue in 2021
    3.5 Human Microbiome Sequencing Technology Key Players Head office and Area Served
    3.6 Key Players Human Microbiome Sequencing Technology Product Solution and Service
    3.7 Date of Enter into Human Microbiome Sequencing Technology Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Human Microbiome Sequencing Technology Breakdown Data by Type
    4.1 Global Human Microbiome Sequencing Technology Historic Market Size by Type (2017-2022)
    4.2 Global Human Microbiome Sequencing Technology Forecasted Market Size by Type (2023-2028)
5 Human Microbiome Sequencing Technology Breakdown Data by Application
    5.1 Global Human Microbiome Sequencing Technology Historic Market Size by Application (2017-2022)
    5.2 Global Human Microbiome Sequencing Technology Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Human Microbiome Sequencing Technology Market Size (2017-2028)
    6.2 North America Human Microbiome Sequencing Technology Market Size by Country (2017-2022)
    6.3 North America Human Microbiome Sequencing Technology Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Human Microbiome Sequencing Technology Market Size (2017-2028)
    7.2 Europe Human Microbiome Sequencing Technology Market Size by Country (2017-2022)
    7.3 Europe Human Microbiome Sequencing Technology Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Human Microbiome Sequencing Technology Market Size (2017-2028)
    8.2 Asia-Pacific Human Microbiome Sequencing Technology Market Size by Country (2017-2022)
    8.3 Asia-Pacific Human Microbiome Sequencing Technology Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Human Microbiome Sequencing Technology Market Size (2017-2028)
    9.2 Latin America Human Microbiome Sequencing Technology Market Size by Country (2017-2022)
    9.3 Latin America Human Microbiome Sequencing Technology Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Human Microbiome Sequencing Technology Market Size (2017-2028)
    10.2 Middle East & Africa Human Microbiome Sequencing Technology Market Size by Country (2017-2022)
    10.3 Middle East & Africa Human Microbiome Sequencing Technology Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Baseclear B.V.
        11.1.1 Baseclear B.V. Company Detail
        11.1.2 Baseclear B.V. Business Overview
        11.1.3 Baseclear B.V. Human Microbiome Sequencing Technology Introduction
        11.1.4 Baseclear B.V. Revenue in Human Microbiome Sequencing Technology Business (2017-2022)
        11.1.5 Baseclear B.V. Recent Development
    11.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd
        11.2.1 Beijing Genomics Institute (BGI) Genomics Co., Ltd Company Detail
        11.2.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd Business Overview
        11.2.3 Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Technology Introduction
        11.2.4 Beijing Genomics Institute (BGI) Genomics Co., Ltd Revenue in Human Microbiome Sequencing Technology Business (2017-2022)
        11.2.5 Beijing Genomics Institute (BGI) Genomics Co., Ltd Recent Development
    11.3 Charles River Laboratories International Inc.
        11.3.1 Charles River Laboratories International Inc. Company Detail
        11.3.2 Charles River Laboratories International Inc. Business Overview
        11.3.3 Charles River Laboratories International Inc. Human Microbiome Sequencing Technology Introduction
        11.3.4 Charles River Laboratories International Inc. Revenue in Human Microbiome Sequencing Technology Business (2017-2022)
        11.3.5 Charles River Laboratories International Inc. Recent Development
    11.4 Clinical Microbiomics A/S
        11.4.1 Clinical Microbiomics A/S Company Detail
        11.4.2 Clinical Microbiomics A/S Business Overview
        11.4.3 Clinical Microbiomics A/S Human Microbiome Sequencing Technology Introduction
        11.4.4 Clinical Microbiomics A/S Revenue in Human Microbiome Sequencing Technology Business (2017-2022)
        11.4.5 Clinical Microbiomics A/S Recent Development
    11.5 Eurofins Scientific SE
        11.5.1 Eurofins Scientific SE Company Detail
        11.5.2 Eurofins Scientific SE Business Overview
        11.5.3 Eurofins Scientific SE Human Microbiome Sequencing Technology Introduction
        11.5.4 Eurofins Scientific SE Revenue in Human Microbiome Sequencing Technology Business (2017-2022)
        11.5.5 Eurofins Scientific SE Recent Development
    11.6 GENEWIZ, Inc.
        11.6.1 GENEWIZ, Inc. Company Detail
        11.6.2 GENEWIZ, Inc. Business Overview
        11.6.3 GENEWIZ, Inc. Human Microbiome Sequencing Technology Introduction
        11.6.4 GENEWIZ, Inc. Revenue in Human Microbiome Sequencing Technology Business (2017-2022)
        11.6.5 GENEWIZ, Inc. Recent Development
    11.7 Illumina, Inc.
        11.7.1 Illumina, Inc. Company Detail
        11.7.2 Illumina, Inc. Business Overview
        11.7.3 Illumina, Inc. Human Microbiome Sequencing Technology Introduction
        11.7.4 Illumina, Inc. Revenue in Human Microbiome Sequencing Technology Business (2017-2022)
        11.7.5 Illumina, Inc. Recent Development
    11.8 Novogene Corporation
        11.8.1 Novogene Corporation Company Detail
        11.8.2 Novogene Corporation Business Overview
        11.8.3 Novogene Corporation Human Microbiome Sequencing Technology Introduction
        11.8.4 Novogene Corporation Revenue in Human Microbiome Sequencing Technology Business (2017-2022)
        11.8.5 Novogene Corporation Recent Development
    11.9 OraSure Technologies, Inc.
        11.9.1 OraSure Technologies, Inc. Company Detail
        11.9.2 OraSure Technologies, Inc. Business Overview
        11.9.3 OraSure Technologies, Inc. Human Microbiome Sequencing Technology Introduction
        11.9.4 OraSure Technologies, Inc. Revenue in Human Microbiome Sequencing Technology Business (2017-2022)
        11.9.5 OraSure Technologies, Inc. Recent Development
    11.10 Oxford Nanopore Technologies, Inc.
        11.10.1 Oxford Nanopore Technologies, Inc. Company Detail
        11.10.2 Oxford Nanopore Technologies, Inc. Business Overview
        11.10.3 Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Technology Introduction
        11.10.4 Oxford Nanopore Technologies, Inc. Revenue in Human Microbiome Sequencing Technology Business (2017-2022)
        11.10.5 Oxford Nanopore Technologies, Inc. Recent Development
    11.11 Pacific Biosciences of California, Inc.
        11.11.1 Pacific Biosciences of California, Inc. Company Detail
        11.11.2 Pacific Biosciences of California, Inc. Business Overview
        11.11.3 Pacific Biosciences of California, Inc. Human Microbiome Sequencing Technology Introduction
        11.11.4 Pacific Biosciences of California, Inc. Revenue in Human Microbiome Sequencing Technology Business (2017-2022)
        11.11.5 Pacific Biosciences of California, Inc. Recent Development
    11.12 QIAGEN N.V.
        11.12.1 QIAGEN N.V. Company Detail
        11.12.2 QIAGEN N.V. Business Overview
        11.12.3 QIAGEN N.V. Human Microbiome Sequencing Technology Introduction
        11.12.4 QIAGEN N.V. Revenue in Human Microbiome Sequencing Technology Business (2017-2022)
        11.12.5 QIAGEN N.V. Recent Development
    11.13 Second Genome, Inc.
        11.13.1 Second Genome, Inc. Company Detail
        11.13.2 Second Genome, Inc. Business Overview
        11.13.3 Second Genome, Inc. Human Microbiome Sequencing Technology Introduction
        11.13.4 Second Genome, Inc. Revenue in Human Microbiome Sequencing Technology Business (2017-2022)
        11.13.5 Second Genome, Inc. Recent Development
    11.14 Thermo Fisher Scientific Inc.
        11.14.1 Thermo Fisher Scientific Inc. Company Detail
        11.14.2 Thermo Fisher Scientific Inc. Business Overview
        11.14.3 Thermo Fisher Scientific Inc. Human Microbiome Sequencing Technology Introduction
        11.14.4 Thermo Fisher Scientific Inc. Revenue in Human Microbiome Sequencing Technology Business (2017-2022)
        11.14.5 Thermo Fisher Scientific Inc. Recent Development
    11.15 Viome, Inc.
        11.15.1 Viome, Inc. Company Detail
        11.15.2 Viome, Inc. Business Overview
        11.15.3 Viome, Inc. Human Microbiome Sequencing Technology Introduction
        11.15.4 Viome, Inc. Revenue in Human Microbiome Sequencing Technology Business (2017-2022)
        11.15.5 Viome, Inc. Recent Development
    11.16 CosmosID
        11.16.1 CosmosID Company Detail
        11.16.2 CosmosID Business Overview
        11.16.3 CosmosID Human Microbiome Sequencing Technology Introduction
        11.16.4 CosmosID Revenue in Human Microbiome Sequencing Technology Business (2017-2022)
        11.16.5 CosmosID Recent Development
    11.17 Leucine Rich Bio Pvt. Ltd.
        11.17.1 Leucine Rich Bio Pvt. Ltd. Company Detail
        11.17.2 Leucine Rich Bio Pvt. Ltd. Business Overview
        11.17.3 Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Technology Introduction
        11.17.4 Leucine Rich Bio Pvt. Ltd. Revenue in Human Microbiome Sequencing Technology Business (2017-2022)
        11.17.5 Leucine Rich Bio Pvt. Ltd. Recent Development
    11.18 Microba
        11.18.1 Microba Company Detail
        11.18.2 Microba Business Overview
        11.18.3 Microba Human Microbiome Sequencing Technology Introduction
        11.18.4 Microba Revenue in Human Microbiome Sequencing Technology Business (2017-2022)
        11.18.5 Microba Recent Development
    11.19 Microbiome Insights Inc.
        11.19.1 Microbiome Insights Inc. Company Detail
        11.19.2 Microbiome Insights Inc. Business Overview
        11.19.3 Microbiome Insights Inc. Human Microbiome Sequencing Technology Introduction
        11.19.4 Microbiome Insights Inc. Revenue in Human Microbiome Sequencing Technology Business (2017-2022)
        11.19.5 Microbiome Insights Inc. Recent Development
    11.20 Molzym GmbH & Co. KG
        11.20.1 Molzym GmbH & Co. KG Company Detail
        11.20.2 Molzym GmbH & Co. KG Business Overview
        11.20.3 Molzym GmbH & Co. KG Human Microbiome Sequencing Technology Introduction
        11.20.4 Molzym GmbH & Co. KG Revenue in Human Microbiome Sequencing Technology Business (2017-2022)
        11.20.5 Molzym GmbH & Co. KG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Human Microbiome Sequencing Technology Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Traditional Sequencing Technologies Table 3. Key Players of Next-Generation Sequencing Table 4. Key Players of Third Generation Sequencing Table 5. Global Human Microbiome Sequencing Technology Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Human Microbiome Sequencing Technology Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Human Microbiome Sequencing Technology Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Human Microbiome Sequencing Technology Market Share by Region (2017-2022) Table 9. Global Human Microbiome Sequencing Technology Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Human Microbiome Sequencing Technology Market Share by Region (2023-2028) Table 11. Human Microbiome Sequencing Technology Market Trends Table 12. Human Microbiome Sequencing Technology Market Drivers Table 13. Human Microbiome Sequencing Technology Market Challenges Table 14. Human Microbiome Sequencing Technology Market Restraints Table 15. Global Human Microbiome Sequencing Technology Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Human Microbiome Sequencing Technology Market Share by Players (2017-2022) Table 17. Global Top Human Microbiome Sequencing Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Sequencing Technology as of 2021) Table 18. Ranking of Global Top Human Microbiome Sequencing Technology Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Human Microbiome Sequencing Technology Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Human Microbiome Sequencing Technology Product Solution and Service Table 22. Date of Enter into Human Microbiome Sequencing Technology Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Human Microbiome Sequencing Technology Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Human Microbiome Sequencing Technology Revenue Market Share by Type (2017-2022) Table 26. Global Human Microbiome Sequencing Technology Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Human Microbiome Sequencing Technology Revenue Market Share by Type (2023-2028) Table 28. Global Human Microbiome Sequencing Technology Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Human Microbiome Sequencing Technology Revenue Market Share by Application (2017-2022) Table 30. Global Human Microbiome Sequencing Technology Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Human Microbiome Sequencing Technology Revenue Market Share by Application (2023-2028) Table 32. North America Human Microbiome Sequencing Technology Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Human Microbiome Sequencing Technology Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Human Microbiome Sequencing Technology Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Human Microbiome Sequencing Technology Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Human Microbiome Sequencing Technology Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Human Microbiome Sequencing Technology Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Human Microbiome Sequencing Technology Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Human Microbiome Sequencing Technology Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Human Microbiome Sequencing Technology Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Human Microbiome Sequencing Technology Market Size by Country (2023-2028) & (US$ Million) Table 42. Baseclear B.V. Company Detail Table 43. Baseclear B.V. Business Overview Table 44. Baseclear B.V. Human Microbiome Sequencing Technology Product Table 45. Baseclear B.V. Revenue in Human Microbiome Sequencing Technology Business (2017-2022) & (US$ Million) Table 46. Baseclear B.V. Recent Development Table 47. Beijing Genomics Institute (BGI) Genomics Co., Ltd Company Detail Table 48. Beijing Genomics Institute (BGI) Genomics Co., Ltd Business Overview Table 49. Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Technology Product Table 50. Beijing Genomics Institute (BGI) Genomics Co., Ltd Revenue in Human Microbiome Sequencing Technology Business (2017-2022) & (US$ Million) Table 51. Beijing Genomics Institute (BGI) Genomics Co., Ltd Recent Development Table 52. Charles River Laboratories International Inc. Company Detail Table 53. Charles River Laboratories International Inc. Business Overview Table 54. Charles River Laboratories International Inc. Human Microbiome Sequencing Technology Product Table 55. Charles River Laboratories International Inc. Revenue in Human Microbiome Sequencing Technology Business (2017-2022) & (US$ Million) Table 56. Charles River Laboratories International Inc. Recent Development Table 57. Clinical Microbiomics A/S Company Detail Table 58. Clinical Microbiomics A/S Business Overview Table 59. Clinical Microbiomics A/S Human Microbiome Sequencing Technology Product Table 60. Clinical Microbiomics A/S Revenue in Human Microbiome Sequencing Technology Business (2017-2022) & (US$ Million) Table 61. Clinical Microbiomics A/S Recent Development Table 62. Eurofins Scientific SE Company Detail Table 63. Eurofins Scientific SE Business Overview Table 64. Eurofins Scientific SE Human Microbiome Sequencing Technology Product Table 65. Eurofins Scientific SE Revenue in Human Microbiome Sequencing Technology Business (2017-2022) & (US$ Million) Table 66. Eurofins Scientific SE Recent Development Table 67. GENEWIZ, Inc. Company Detail Table 68. GENEWIZ, Inc. Business Overview Table 69. GENEWIZ, Inc. Human Microbiome Sequencing Technology Product Table 70. GENEWIZ, Inc. Revenue in Human Microbiome Sequencing Technology Business (2017-2022) & (US$ Million) Table 71. GENEWIZ, Inc. Recent Development Table 72. Illumina, Inc. Company Detail Table 73. Illumina, Inc. Business Overview Table 74. Illumina, Inc. Human Microbiome Sequencing Technology Product Table 75. Illumina, Inc. Revenue in Human Microbiome Sequencing Technology Business (2017-2022) & (US$ Million) Table 76. Illumina, Inc. Recent Development Table 77. Novogene Corporation Company Detail Table 78. Novogene Corporation Business Overview Table 79. Novogene Corporation Human Microbiome Sequencing Technology Product Table 80. Novogene Corporation Revenue in Human Microbiome Sequencing Technology Business (2017-2022) & (US$ Million) Table 81. Novogene Corporation Recent Development Table 82. OraSure Technologies, Inc. Company Detail Table 83. OraSure Technologies, Inc. Business Overview Table 84. OraSure Technologies, Inc. Human Microbiome Sequencing Technology Product Table 85. OraSure Technologies, Inc. Revenue in Human Microbiome Sequencing Technology Business (2017-2022) & (US$ Million) Table 86. OraSure Technologies, Inc. Recent Development Table 87. Oxford Nanopore Technologies, Inc. Company Detail Table 88. Oxford Nanopore Technologies, Inc. Business Overview Table 89. Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Technology Product Table 90. Oxford Nanopore Technologies, Inc. Revenue in Human Microbiome Sequencing Technology Business (2017-2022) & (US$ Million) Table 91. Oxford Nanopore Technologies, Inc. Recent Development Table 92. Pacific Biosciences of California, Inc. Company Detail Table 93. Pacific Biosciences of California, Inc. Business Overview Table 94. Pacific Biosciences of California, Inc. Human Microbiome Sequencing TechnologyProduct Table 95. Pacific Biosciences of California, Inc. Revenue in Human Microbiome Sequencing Technology Business (2017-2022) & (US$ Million) Table 96. Pacific Biosciences of California, Inc. Recent Development Table 97. QIAGEN N.V. Company Detail Table 98. QIAGEN N.V. Business Overview Table 99. QIAGEN N.V. Human Microbiome Sequencing TechnologyProduct Table 100. QIAGEN N.V. Revenue in Human Microbiome Sequencing Technology Business (2017-2022) & (US$ Million) Table 101. QIAGEN N.V. Recent Development Table 102. Second Genome, Inc. Company Detail Table 103. Second Genome, Inc. Business Overview Table 104. Second Genome, Inc. Human Microbiome Sequencing TechnologyProduct Table 105. Second Genome, Inc. Revenue in Human Microbiome Sequencing Technology Business (2017-2022) & (US$ Million) Table 106. Second Genome, Inc. Recent Development Table 107. Thermo Fisher Scientific Inc. Company Detail Table 108. Thermo Fisher Scientific Inc. Business Overview Table 109. Thermo Fisher Scientific Inc. Human Microbiome Sequencing TechnologyProduct Table 110. Thermo Fisher Scientific Inc. Revenue in Human Microbiome Sequencing Technology Business (2017-2022) & (US$ Million) Table 111. Thermo Fisher Scientific Inc. Recent Development Table 112. Viome, Inc. Company Detail Table 113. Viome, Inc. Business Overview Table 114. Viome, Inc. Human Microbiome Sequencing TechnologyProduct Table 115. Viome, Inc. Revenue in Human Microbiome Sequencing Technology Business (2017-2022) & (US$ Million) Table 116. Viome, Inc. Recent Development Table 117. CosmosID Company Detail Table 118. CosmosID Business Overview Table 119. CosmosID Human Microbiome Sequencing TechnologyProduct Table 120. CosmosID Revenue in Human Microbiome Sequencing Technology Business (2017-2022) & (US$ Million) Table 121. CosmosID Recent Development Table 122. Leucine Rich Bio Pvt. Ltd. Company Detail Table 123. Leucine Rich Bio Pvt. Ltd. Business Overview Table 124. Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing TechnologyProduct Table 125. Leucine Rich Bio Pvt. Ltd. Revenue in Human Microbiome Sequencing Technology Business (2017-2022) & (US$ Million) Table 126. Leucine Rich Bio Pvt. Ltd. Recent Development Table 127. Microba Company Detail Table 128. Microba Business Overview Table 129. Microba Human Microbiome Sequencing TechnologyProduct Table 130. Microba Revenue in Human Microbiome Sequencing Technology Business (2017-2022) & (US$ Million) Table 131. Microba Recent Development Table 132. Microbiome Insights Inc. Company Detail Table 133. Microbiome Insights Inc. Business Overview Table 134. Microbiome Insights Inc. Human Microbiome Sequencing TechnologyProduct Table 135. Microbiome Insights Inc. Revenue in Human Microbiome Sequencing Technology Business (2017-2022) & (US$ Million) Table 136. Microbiome Insights Inc. Recent Development Table 137. Molzym GmbH & Co. KG Company Detail Table 138. Molzym GmbH & Co. KG Business Overview Table 139. Molzym GmbH & Co. KG Human Microbiome Sequencing TechnologyProduct Table 140. Molzym GmbH & Co. KG Revenue in Human Microbiome Sequencing Technology Business (2017-2022) & (US$ Million) Table 141. Molzym GmbH & Co. KG Recent Development Table 142. Research Programs/Design for This Report Table 143. Key Data Information from Secondary Sources Table 144. Key Data Information from Primary Sources List of Figures Figure 1. Global Human Microbiome Sequencing Technology Market Share by Type: 2021 VS 2028 Figure 2. Traditional Sequencing Technologies Features Figure 3. Next-Generation Sequencing Features Figure 4. Third Generation Sequencing Features Figure 5. Global Human Microbiome Sequencing Technology Market Share by Application in 2021 & 2028 Figure 6. Research and Academic Institutions Case Studies Figure 7. Pharmaceutical and Biotechnology Companies Case Studies Figure 8. Hospital and Clinic Case Studies Figure 9. Others Case Studies Figure 10. Human Microbiome Sequencing Technology Report Years Considered Figure 11. Global Human Microbiome Sequencing Technology Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Human Microbiome Sequencing Technology Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Human Microbiome Sequencing Technology Market Share by Region: 2021 VS 2028 Figure 14. Global Human Microbiome Sequencing Technology Market Share by Players in 2021 Figure 15. Global Top Human Microbiome Sequencing Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Sequencing Technology as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Human Microbiome Sequencing Technology Revenue in 2021 Figure 17. North America Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. North America Human Microbiome Sequencing Technology Market Share by Country (2017-2028) Figure 19. United States Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Human Microbiome Sequencing Technology Market Share by Country (2017-2028) Figure 23. Germany Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. France Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. U.K. Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Italy Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Russia Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Nordic Countries Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Human Microbiome Sequencing Technology Market Share by Region (2017-2028) Figure 31. China Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Japan Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. South Korea Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Southeast Asia Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. India Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Australia Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Human Microbiome Sequencing Technology Market Share by Country (2017-2028) Figure 39. Mexico Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Brazil Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Human Microbiome Sequencing Technology Market Share by Country (2017-2028) Figure 43. Turkey Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Saudi Arabia Human Microbiome Sequencing Technology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Baseclear B.V. Revenue Growth Rate in Human Microbiome Sequencing Technology Business (2017-2022) Figure 46. Beijing Genomics Institute (BGI) Genomics Co., Ltd Revenue Growth Rate in Human Microbiome Sequencing Technology Business (2017-2022) Figure 47. Charles River Laboratories International Inc. Revenue Growth Rate in Human Microbiome Sequencing Technology Business (2017-2022) Figure 48. Clinical Microbiomics A/S Revenue Growth Rate in Human Microbiome Sequencing Technology Business (2017-2022) Figure 49. Eurofins Scientific SE Revenue Growth Rate in Human Microbiome Sequencing Technology Business (2017-2022) Figure 50. GENEWIZ, Inc. Revenue Growth Rate in Human Microbiome Sequencing Technology Business (2017-2022) Figure 51. Illumina, Inc. Revenue Growth Rate in Human Microbiome Sequencing Technology Business (2017-2022) Figure 52. Novogene Corporation Revenue Growth Rate in Human Microbiome Sequencing Technology Business (2017-2022) Figure 53. OraSure Technologies, Inc. Revenue Growth Rate in Human Microbiome Sequencing Technology Business (2017-2022) Figure 54. Oxford Nanopore Technologies, Inc. Revenue Growth Rate in Human Microbiome Sequencing Technology Business (2017-2022) Figure 55. Pacific Biosciences of California, Inc. Revenue Growth Rate in Human Microbiome Sequencing Technology Business (2017-2022) Figure 56. QIAGEN N.V. Revenue Growth Rate in Human Microbiome Sequencing Technology Business (2017-2022) Figure 57. Second Genome, Inc. Revenue Growth Rate in Human Microbiome Sequencing Technology Business (2017-2022) Figure 58. Thermo Fisher Scientific Inc. Revenue Growth Rate in Human Microbiome Sequencing Technology Business (2017-2022) Figure 59. Viome, Inc. Revenue Growth Rate in Human Microbiome Sequencing Technology Business (2017-2022) Figure 60. CosmosID Revenue Growth Rate in Human Microbiome Sequencing Technology Business (2017-2022) Figure 61. Leucine Rich Bio Pvt. Ltd. Revenue Growth Rate in Human Microbiome Sequencing Technology Business (2017-2022) Figure 62. Microba Revenue Growth Rate in Human Microbiome Sequencing Technology Business (2017-2022) Figure 63. Microbiome Insights Inc. Revenue Growth Rate in Human Microbiome Sequencing Technology Business (2017-2022) Figure 64. Molzym GmbH & Co. KG Revenue Growth Rate in Human Microbiome Sequencing Technology Business (2017-2022) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us